The Food and Drug Administration took a highly unusual step this week: It acknowledged that a widely used generic drug — a copycat of the antidepressant Wellbutrin XL — was not the equivalent of the original drug produced by GlaxoSmithKline since 2003.
WT news feed
↧
Generic antidepressant pulled from U.S. shelves after FDA finding
↧